Samsung Biologics Co Ltd

KR

SSBIO

Health Care

802000 ₽

Current price

Hold
802000 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    54 / 240

  • Position in country

    1270 / 2780

  • Return on Assets, %

    5.3

    -2.7

  • Net income margin, %

    27

    -6.7

  • EBITDA margin, %

    45.8

    5.6

  • Debt to Equity, %

    19.4

    15.1

  • Intangible assets and goodwill, %

    36.3

    4.7

  • Revenue CAGR 3Y, %

    46.9

    12.8

  • Total Equity change 1Y, %

    6.5

    -2.4

  • Revenue Y, % chg

    21.9

    0

  • P/E

    65.5

    32.1

  • P/BV

    5.7

    2

  • P/S

    15.2

    4.1

  • EV/S

    15.1

    3.6

  • EV/EBITDA

    34.9

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    29.7

    48.9

  • Forward P/E

    55.6

    25.5

  • Forward Dividend Yield, %

    0

    0.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    10.1

Get an analytical review of this company

Competitors

Ranks

  • ST Pharm Co Ltd

    00%

  • Lonza Group AG

    00%

  • Samsung Biologics Co Ltd

    00%

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Agilent Technologies Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • LegoChem Biosciences Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Korea; Republic (S. Korea)

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    41131.7

  • Ticker

    207940.KS

  • ISIN

    KR7207940008

  • IPO date

    2016-11-10

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-28

  • Date fact. publication of reports

    2023-12-31

Company Description

Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products in domestic and overseas markets.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: